Spero Therapeutics (SPRO)
Nasdaq • SPRO • US84833T1034
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 1.9% of free float sold short, 1.8 days to cover, cost to borrow 0.48%. Sign up for live short interest data.
Market Cap
59.4m USD | # 9078 in US
Volume
555.49k shares | 645.44k USD
Shares Outstanding
58.23m
Free Float Shares
80.88% | 47.1m
